ABBOTT LABORATORIES Share-Based Compensation 2007-2026 | ABT
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is ABBOTT LABORATORIES's current share-based compensation?
ABBOTT LABORATORIES (ABT) annual share-based compensation for 2025 was $664.0M, a 1.34% decline from 2024. ABBOTT LABORATORIES share-based compensation for the quarter ending March 31, 2026 was $317.0M.
What was ABBOTT LABORATORIES's share-based compensation in 2024?
ABBOTT LABORATORIES annual share-based compensation for 2024 was $673.0M, a 4.50% increase from 2023.
What was ABBOTT LABORATORIES's share-based compensation in 2023?
ABBOTT LABORATORIES annual share-based compensation for 2023 was $644.0M, a 5.99% decline from 2022.
What is ABBOTT LABORATORIES's 5-year share-based compensation CAGR?
ABBOTT LABORATORIES share-based compensation grew at a compound annual growth rate (CAGR) of 3.99% from FY2020 to FY2025, going from $546.0M to $664.0M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $664.0M | -1.3% | 10-K |
| FY2024 | $673.0M | +4.5% | 10-K |
| FY2023 | $644.0M | -6.0% | 10-K |
| FY2022 | $685.0M | +7.0% | 10-K |
| FY2021 | $640.0M | +17.2% | 10-K |
| FY2020 | $546.0M | +5.2% | 10-K |
| FY2019 | $519.0M | +8.8% | 10-K |
| FY2018 | $477.0M | +17.5% | 10-K |
| FY2017 | $406.0M | +31.0% | 10-K |
| FY2016 | $310.0M | +6.2% | 10-K |
| FY2015 | $292.0M | +18.7% | 10-K |
| FY2014 | $246.0M | -6.1% | 10-K |
| FY2013 | $262.0M | -39.5% | 10-K |
| FY2012 | $433.0M | +13.1% | 10-K |
| FY2011 | $383.0M | -1.1% | 10-K |
| FY2010 | $387.2M | +5.7% | 10-K |
| FY2009 | $366.4M | +5.6% | 10-K |
| FY2008 | $347.0M | -19.2% | 10-K |
| FY2007 | $429.7M | - | 10-K |